ADVFN UK Market News

Category: Market News

  • NextEnergy Solar Fund Schedules Investor Webcasts Ahead of Full-Year Results Release (NESF)

    NextEnergy Solar Fund Schedules Investor Webcasts Ahead of Full-Year Results Release (NESF)

    NextEnergy Solar Fund (LSE:NESF) has announced that it will publish its full-year results for the period ended 31 March 2026 on 22 June 2026. Following the release, the company will host a webcast presentation for investors and analysts later that day, featuring senior representatives from the fund and its investment adviser. The session will include a review of financial and operational performance, strategic developments and a live question-and-answer segment. A recording of the presentation and supporting materials will subsequently be made available on the company’s website.

    In addition to the institutional investor webcast, the fund’s investment adviser will hold a dedicated online presentation for retail shareholders on 23 June 2026 through the Investor Meet Company platform. Participants will have the opportunity to submit questions either before the event or during the live session. By organising separate presentations for institutional and retail audiences, the company is seeking to broaden engagement with shareholders and provide greater transparency ahead of the publication of its latest financial results and operational update.

    The fund’s outlook continues to be affected by weaker earnings performance, including a sharp decline in revenue and two consecutive years of reported losses. Technical indicators also remain challenging, with the shares trading below key moving averages and negative MACD momentum signalling a weak trend. These factors are partially offset by strong and improving operating cash flow, a debt-free balance sheet reported in 2025 and a notably high dividend yield. However, these strengths have yet to fully counterbalance the pressure from earnings weakness and subdued market sentiment.

    More about NextEnergy Solar Fund Limited

    NextEnergy Solar Fund Limited is a London-listed investment company focused on utility-scale solar power generation and energy storage infrastructure. The fund seeks to provide shareholders with attractive risk-adjusted returns, primarily through regular dividend distributions supported by long-term contracted cash flows.

    Its portfolio consists of diversified renewable energy assets, with a significant portion of revenues linked to inflation through UK government-backed subsidy mechanisms. As of 31 March 2026, the fund reported an unaudited gross asset value of £922 million and is classified as an Article 9 fund under the European Union’s sustainable finance framework, reflecting its commitment to sustainable and environmentally focused investments.

  • Orosur Identifies New Mineralised Opportunities at APTA Following Significant Gold Drill Result (OMI)

    Orosur Identifies New Mineralised Opportunities at APTA Following Significant Gold Drill Result (OMI)

    Orosur Mining (LSE:OMI) has announced a significant drilling result from the APTA prospect at its Anzá Project in Colombia, with hole MAP-106A intersecting 229.7 metres grading 0.88 grams per tonne gold. The intercept included several higher-grade sections, with grades reaching up to 7.07 grams per tonne gold. The result further confirms the presence of a large epithermal gold system and has prompted the company to refine its geological interpretation of the Aragon fault zone, where mineralisation appears to be hosted within silicified sedimentary and volcaniclastic rocks.

    The latest drilling has highlighted multiple avenues for future growth at APTA. Orosur plans to continue expanding a deeper high-grade mineralised zone that has already been traced along more than one kilometre of strike length. The company also intends to evaluate the potential for previously unidentified shallow bulk-tonnage mineralisation concealed beneath transported cover and to further investigate a hanging-wall vein structure that may offer attractive development potential. Together, these opportunities significantly enhance the exploration potential of the APTA prospect and could contribute meaningfully to the broader resource base at the Anzá Project.

    The findings strengthen the company’s exploration outlook by demonstrating both scale and geological complexity within the system. As drilling continues, management believes the evolving geological model could support additional discoveries and improve the long-term development prospects of the Anzá district.

    More about Orosur Mining

    Orosur Mining Inc. is a gold exploration and development company listed on both the TSX Venture Exchange and AIM. The company is focused on advancing its wholly owned Anzá Project, located within Colombia’s highly prospective Mid-Cauca gold belt, one of the country’s most significant mineral regions.

    Covering approximately 330 square kilometres, the Anzá Project hosts multiple exploration targets, including the high-grade Pepas and APTA prospects as well as the El Cedro porphyry system. Through ongoing drilling and resource expansion programmes, Orosur aims to unlock the potential of this large land package within a prolific Andean gold district.

  • GSK Agrees $10.6bn Nuvalent Acquisition to Strengthen Lung Cancer Portfolio (GSK)

    GSK Agrees $10.6bn Nuvalent Acquisition to Strengthen Lung Cancer Portfolio (GSK)

    GSK (LSE:GSK) has reached an agreement to acquire Boston-based clinical-stage oncology company Nuvalent in a transaction valued at $10.6 billion. The acquisition will add three key lung cancer programmes to GSK’s pipeline, including the late-stage ROS1 inhibitor zidesamtinib, the ALK inhibitor neladalkib, and a HER2-targeted inhibitor, alongside a broader portfolio of precision oncology assets. The deal is intended to accelerate GSK’s expansion in the lung cancer market and establish a stronger commercial foundation for its B7-H3 antibody-drug conjugate, Ris-Rez.

    The company expects the acquisition to contribute positively to revenue growth from 2027 and to become accretive to core earnings per share from 2029. GSK plans to finance the transaction primarily through debt while maintaining its commitment to shareholder returns and preserving its investment-grade credit rating. The addition of Nuvalent’s targeted therapies is expected to enhance GSK’s oncology strategy and strengthen its position in the treatment of non-small cell lung cancer and other genetically defined cancer indications.

    GSK’s overall outlook continues to be supported by strong operational performance, including healthy margins, improving earnings and an attractive valuation profile. The shares also offer a dividend yield of approximately 3.47%, providing additional support for investors. These strengths are balanced by weaker technical indicators, with the stock trading below key moving averages and exhibiting negative MACD momentum. Financial considerations, including a meaningful level of leverage and periods of uneven free cash flow generation, also remain factors for investors to monitor.

    More about GlaxoSmithKline

    GSK is a global biopharmaceutical company focused on the development of vaccines, specialty medicines and innovative healthcare solutions. The group operates across a range of therapeutic areas and has increasingly prioritised oncology as a key driver of future growth.

    Through a combination of internal research, strategic partnerships and acquisitions, GSK continues to expand its pipeline in high-value disease areas, including respiratory medicine, infectious diseases and cancer. The company has been building a stronger presence in oncology, with particular emphasis on lung cancer and precision medicine approaches designed to target specific genetic drivers of disease.

  • Keller Secures $207m I-40 Contract Expansion as Order Book Reaches Record High (KLR)

    Keller Secures $207m I-40 Contract Expansion as Order Book Reaches Record High (KLR)

    Keller Group plc (LSE:KLR) has been awarded an additional contract variation valued at $207 million for its ongoing involvement in the reconstruction of the I-40 highway in the United States. The latest award expands a series of work packages that the company has been delivering since 2025 and increases the total value of Keller’s participation in the project to approximately $380 million. Around $70 million of this work has already been completed, with the balance expected to be executed over the next two to three years.

    The contract extension has lifted Keller’s order book to a record level of roughly £1.9 billion, providing greater visibility over future revenues and workload. Management said the award reflects both the company’s specialist technical expertise and the confidence of its client in Keller’s ability to deliver complex infrastructure projects. The group also reaffirmed its expectation of reporting full-year 2026 results in line with market forecasts while continuing to play a significant role in one of the United States’ major transport infrastructure upgrades.

    Keller’s outlook is supported by improving financial performance and a valuation that remains attractive relative to earnings. Recent management commentary has highlighted strong free cash flow generation, a net cash balance sheet and a continued focus on enhancing shareholder returns. Technical indicators also remain favourable, reflecting a well-established upward trend in the share price. However, elevated RSI and stochastic readings suggest the stock could be vulnerable to a short-term pullback following its recent gains.

    More about Keller Group plc

    Keller Group plc is the world’s largest specialist geotechnical contractor, delivering foundation engineering, ground improvement and related geotechnical solutions for construction projects around the globe. The company supports a wide range of sectors, including transportation, industrial, commercial, residential and infrastructure development.

    With a workforce of approximately 10,000 employees operating across five continents, Keller undertakes around 5,500 projects each year and generates annual revenues of roughly £3 billion. Its expertise in complex ground engineering and large-scale infrastructure projects has established the company as a leading provider of specialist geotechnical services worldwide.

  • Pantheon Resources Restructures Executive Incentives With Expanded Equity-Based Compensation Plan (PANR)

    Pantheon Resources Restructures Executive Incentives With Expanded Equity-Based Compensation Plan (PANR)

    Pantheon Resources (LSE:PANR) has introduced a revised executive remuneration framework that places a greater emphasis on long-term equity incentives while leaving base salaries unchanged. As part of the overhaul, the company has awarded nearly 20 million restricted stock units to senior management, implemented performance-based vesting conditions linked to the achievement of key strategic milestones, including the securing of a joint venture partner, and granted four million share options to its chairman. The company has also cancelled 11.5 million previously issued options and is seeking additional blocklisting capacity to accommodate future equity awards.

    The updated compensation structure follows an independent benchmarking exercise against comparable US-listed peers and is intended to support the retention of key executives during a pivotal stage in the development of the company’s North Slope assets in Alaska. By increasing the proportion of remuneration delivered through equity, Pantheon aims to strengthen the alignment between management incentives and shareholder returns. The chairman’s enhanced exposure through options and contracts for difference, together with larger long-term awards for executives, reflects a strategic shift towards equity-heavy compensation tied to the successful advancement and commercialisation of the company’s oil and gas projects. However, the approach may result in dilution for existing shareholders as additional shares are issued over time.

    Pantheon’s investment outlook continues to be constrained by weak underlying financial performance, including ongoing losses, limited revenue generation and negative operating and free cash flow. These challenges are partially offset by a relatively low-leverage balance sheet. From a technical perspective, the shares remain in an established upward trend, although momentum indicators suggest the stock is currently heavily overbought, increasing the risk of short-term volatility. Valuation remains difficult to assess given negative earnings and the absence of dividend support.

    More about Pantheon Resources

    Pantheon Resources is an oil and gas exploration and development company focused on advancing the Kodiak and Ahpun projects located on Alaska’s North Slope. The company is listed on both AIM and the OTCQX market and is working to unlock the long-term value of its substantial Alaskan resource base.

    Its strategy centres on progressing field development, attracting strategic partners and advancing commercialisation opportunities across its portfolio. As it moves its projects towards potential production, Pantheon continues to compete for experienced industry talent while seeking to create value from its position in one of North America’s most significant hydrocarbon regions.

  • Silver Bullet Proposes AIM Delisting and Private Company Transition to Support Future Growth (SBDS)

    Silver Bullet Proposes AIM Delisting and Private Company Transition to Support Future Growth (SBDS)

    Silver Bullet (LSE:SBDS) has announced plans to cancel the admission of its ordinary shares to trading on AIM and re-register as a private limited company. Shareholders will be asked to approve the proposal at a general meeting scheduled for 25 June 2026, with the company targeting 8 July 2026 for the cancellation of its AIM listing. According to the board, the public market valuation does not accurately reflect the underlying value of the business, while the costs and regulatory obligations associated with maintaining an AIM quotation have become increasingly burdensome.

    The directors believe that operating as a private company would provide greater flexibility to pursue growth opportunities and secure funding on terms more aligned with the company’s strategic objectives. Management also highlighted ambitions to continue expanding its presence in North America and stated that resources currently devoted to maintaining the listing could be redirected towards business development initiatives. To provide some liquidity for existing shareholders following the delisting, Silver Bullet intends to establish a matched bargain facility that will enable off-market trading of shares. However, the company cautioned that liquidity and marketability are likely to be more limited than under its current AIM listing.

    The investment outlook remains influenced by several financial challenges, including ongoing losses, elevated leverage and negative operating cash flow, despite continued revenue growth and strong gross margins. Technical indicators present a mixed picture but remain generally weak, with the share price trading below key longer-term moving averages. Valuation metrics also remain constrained by the company’s loss-making status and the absence of dividend payments.

    More about Silver Bullet Data Services Group plc

    Silver Bullet Data Services Group plc is a technology and data solutions provider focused on helping businesses unlock value from their data through a range of digital products and services. The company works with clients across multiple sectors, with a particular emphasis on supporting data-driven decision-making and marketing effectiveness.

    The group has established a growing presence in North America and has continued to expand its operations while delivering consistent revenue growth. Although the business has achieved positive EBITDA performance, management believes that its public market valuation and share trading liquidity have failed to keep pace with operational progress, prompting the proposed move to private ownership.

  • Vianet Grows Recurring Revenue, Strengthens Balance Sheet and Completes Leadership Transition (VNET)

    Vianet Grows Recurring Revenue, Strengthens Balance Sheet and Completes Leadership Transition (VNET)

    Vianet Group (LSE:VNET) delivered steady progress in the year ended 31 March 2026, reporting revenue growth of 1.5% to £15.5 million while increasing the proportion of recurring income to 88% of total sales. The higher recurring revenue contribution helped maintain a gross margin of 68% and supported a modest improvement in adjusted profitability. The group also strengthened its financial position by moving into net cash, increasing year-end cash balances by 22%, and significantly raising its dividend. Improvements at its US operation further enhanced earnings quality through lower losses and a stronger revenue mix.

    The company’s hospitality division recorded mid-single-digit growth in both revenue and profit, supported by new customer installations, contract wins and the successful integration of Beverage Metrics. Within the smart machines segment, Vianet continued to expand its installed base of cashless payment devices despite market disruption associated with the transition from 3G to 4G technology. The group also secured a major enterprise hospitality contract in the United States and expanded its sales opportunities through a partnership with Fintech Inc. Alongside these operational developments, Vianet completed a planned management transition, appointing Craig Brocklehurst as chief executive officer while James Dickson returned to the role of non-executive chairman, reinforcing continuity and governance stability.

    Vianet’s outlook is supported by strong cash generation, an increasingly recurring revenue base and ongoing strategic initiatives across its core markets. These strengths are balanced by weaker technical indicators, which currently point to bearish momentum in the share price. From a valuation perspective, the stock offers a reasonable proposition, complemented by a growing dividend that provides a degree of income support for investors.

    More about Vianet Group plc

    Vianet Group plc is an international technology company providing data intelligence, payment solutions and operational insights through a connected ecosystem of hardware, software and analytics platforms. Its products are designed to help customers improve efficiency, increase revenues and enhance decision-making through real-time data collection and analysis.

    The company serves the hospitality and unattended retail sectors, offering smart machine telemetry, cashless payment technology and AI-powered analytics solutions. Its customer base includes vending machine operators, fuel forecourts, pubs, bars and restaurant groups across the UK and the United States, where it continues to expand its presence through both organic growth and strategic partnerships.

  • Seraphim Space Positioned for Significant NAV Increase Following ICEYE’s €10bn Funding Valuation (SSIT)

    Seraphim Space Positioned for Significant NAV Increase Following ICEYE’s €10bn Funding Valuation (SSIT)

    Seraphim Space Investment Trust (LSE:SSIT) has announced that its largest portfolio company, ICEYE, has secured commitments for a €450 million Series F funding round led by General Atlantic. The transaction values the Finnish space-based intelligence and Earth observation specialist at more than €10 billion, reflecting growing investor demand for technologies supporting defence, security and critical infrastructure resilience. Together with a secondary share placement that is expected to take the total transaction value beyond €1 billion, the fundraising highlights the increasing strategic relevance of sovereign space intelligence capabilities.

    Based on the valuation disclosed by ICEYE, Seraphim estimates that the fair value of its holding could increase by approximately £202 million. This represents a 102% uplift in the value of its stake and translates into an estimated 73 pence increase in net asset value per share, subject to completion of the financing and standard valuation review processes. The trust expects the uplift to be reflected in its financial results for the year ending 30 June 2026. The development further reinforces Seraphim’s position as a listed vehicle providing exposure to leading private SpaceTech businesses benefiting from long-term technological, commercial and geopolitical trends.

    While the potential revaluation is highly positive, the company’s broader outlook remains constrained by persistently negative operating cash flow and earnings that are heavily influenced by portfolio valuation movements. These factors are partly offset by a conservative balance sheet with no debt. From a technical standpoint, the shares continue to display weak short-term momentum, trading below key near-term moving averages, while a relatively low price-to-earnings ratio offers only limited support to the investment case.

    More about Seraphim Space Investment Trust Plc

    Seraphim Space Investment Trust plc is the first publicly listed investment fund dedicated exclusively to the global SpaceTech sector. The company focuses primarily on growth-stage private businesses developing technologies and services that operate in or leverage space infrastructure.

    Listed in London, the trust invests across a range of high-growth themes including climate monitoring, communications, mobility, defence, cyber security and Earth observation. Its strategy centres on identifying category-leading companies with scalable technologies, strong competitive positioning and the potential to benefit from the accelerating commercialisation of space.

  • Andrada Reports Strong Lithium Grades and Polymetallic Upside at Namibia’s Lithium Ridge Project (ATM)

    Andrada Reports Strong Lithium Grades and Polymetallic Upside at Namibia’s Lithium Ridge Project (ATM)

    Andrada Mining (LSE:ATM) has released a further set of drilling results from its Lithium Ridge project in Namibia, with the latest assays continuing to demonstrate high-grade lithium mineralisation from surface and at depth across several diamond drill holes. Notable intersections included 9.05 metres grading 2.28% Li2O, while near-surface zones returned grades of up to 3.46% Li2O, reinforcing confidence in both the quality and extent of the mineralised system.

    The results form part of the company’s expanded Stage 1 drilling programme, which has now been completed and comprised 143 drill holes for a total of 16,525 metres of oriented core. Andrada is accelerating logging and sampling activities as it progresses evaluation of the project. In addition to the strong lithium results, drilling continues to identify consistent tin and tantalum mineralisation, highlighting the potential for a polymetallic development. This multi-commodity profile could improve future project economics and further strengthen Andrada’s exposure to the rapidly growing critical minerals market.

    Despite the operational progress, the company’s outlook remains influenced by weak financial performance, including ongoing losses and negative operating and free cash flow, although revenues have continued to grow. Technical indicators also remain challenging, reflecting a broader downward trend and weak market momentum. Valuation metrics provide limited support, with the company remaining loss-making and offering no dividend yield.

    More about Andrada Mining

    Andrada Mining Limited is a Namibia-focused mining company and established tin producer with a portfolio of critical minerals assets spanning production, development and exploration. Alongside its tin operations, the company is advancing lithium and other strategic mineral opportunities that support the global energy transition.

    The company is developing the Lithium Ridge project in partnership with SQM, one of the world’s leading lithium producers. Through this collaboration, Andrada aims to unlock the project’s potential and strengthen its position within the battery materials and critical minerals supply chain, while leveraging its expertise in Namibia’s mining sector.

  • PureTech Highlights Seaport Progress as GlyphAgo Advances Following Positive Phase 1 Anxiety Trial Results (PRTC)

    PureTech Highlights Seaport Progress as GlyphAgo Advances Following Positive Phase 1 Anxiety Trial Results (PRTC)

    PureTech Health (LSE:PRTC) has reported further progress from its Founded Entity, Seaport Therapeutics, which announced positive multiple-ascending dose results from a Phase 1 proof-of-concept study evaluating GlyphAgo. The oral prodrug of agomelatine has been engineered to improve lymphatic absorption while limiting liver exposure. Data from the trial showed that repeated dosing over seven days produced therapeutic agomelatine concentrations alongside favourable safety, tolerability and pharmacokinetic profiles, with no liver-related adverse events reported. The findings support dose selection for future studies and reinforce GlyphAgo’s potential as a differentiated treatment option for generalized anxiety disorder.

    The latest results build on earlier single-ascending dose and crossover studies that demonstrated substantially higher bioavailability and reduced pharmacokinetic variability compared with standard agomelatine. Together, the findings strengthen confidence in Seaport’s development strategy and provide further validation of its proprietary Glyph platform. The company intends to move GlyphAgo into two parallel Phase 2 studies in generalized anxiety disorder beginning in 2026 and 2027, with one trial focused on sleep-related pharmacology and the other potentially serving as a registration-enabling efficacy study. The programme reflects PureTech’s strategy of creating, developing and scaling platform-based neuropsychiatric therapies through its Founded Entities.

    While the clinical and portfolio developments are encouraging, PureTech’s overall outlook remains tempered by continued operating losses, negative free cash flow and a relatively modest revenue base. These challenges are partly balanced by a solid balance sheet and recent improvements in operating performance. Updates from management regarding clinical progress, portfolio advancement and funding runway have strengthened the investment case, although execution and financing risks remain significant. Technical indicators remain broadly neutral, while valuation metrics continue to be constrained by negative earnings and the absence of dividend payments.

    More about PureTech Health

    PureTech Health is a UK-listed biotherapeutics company that operates a hub-and-spoke model, creating and developing Founded Entities that combine clinically validated pharmacology with targeted innovation to address significant unmet medical needs. Through this approach, the company seeks to generate and advance new therapeutic platforms across a range of disease areas.

    One of its Founded Entities, Seaport Therapeutics, is a Nasdaq-listed clinical-stage biotechnology company focused on developing next-generation neuropsychiatric medicines. Using its proprietary Glyph platform, Seaport aims to improve the bioavailability, consistency and safety profile of established therapeutic mechanisms for conditions including anxiety, depression and related neurological disorders.